Home
About Us
Coding Topics for Pharmacogenetic
| Topic | GTE Synopsis | GTE Report |
| Abelson Murine Leukemia Viral Oncogene Homolog 1 (ABL1) Variant Testing in Acquired Tyrosine Kinase Inhibitor (TKI) Resistance | ✓ | Pending |
| BCR-ABL | ✓ | ✓ |
| BRAF p.Val600Glu (V600E) for Assessment of Treatment Options in Metastatic Colorectal Cancer | ✓ | ✓ |
| CYP2C19 Variant Testing for Determining Response to Clopidogrel | ✓ | ✓ |
| CYP2C9 and VKORC1 Variant Testing for Management of Warfarin Dose Initiation | ✓ | ✓ |
| CYP2D6 Genotyping for Dose Management of Tamoxifen During Breast Cancer Treatment | ✓ | ✓ |
| Cytochrome P450 3A4 (CYP3A4) for Drug Metabolism | ✓ | N/A * |
| Cytochrome P450 3A5 (CYP3A5) for Drug Metabolism | ✓ | N/A * |
| FIP1L1-PDGFRA Fusion Gene Testing for Imatinib-Sensitive Chronic Eosinophilic Leukemia/Hypereosinophilic Syndrome (CEL/HES) | ✓ | Pending |
| KIT and PDGFRA Testing for Diagnosis of GIST | ✓ | ✓ |
| KIT and PDGFRA Testing for Diagnosis of GIST | ✓ | ✓ |
| KIT and PDGFRA Testing for Primary Treatment of GIST | ✓ | ✓ |
| KIT and PDGFRA Testing for Prognosis of GIST | ✓ | ✓ |
| KIT and PDGFRA Testing for Secondary Treatment of GIST | ✓ | ✓ |
| KRAS Sequence Variant Analysis (Colorectal Cancer) | ✓ | ✓ |
| KRAS Sequence Variant Analysis (Non-small Cell Lung Cancer) | ✓ | ✓ |
| Neuroblastoma RAS Viral Oncogene (NRAS) for Prediction of Treatment Response in Colorectal Cancer | ✓ | Pending |
| TheraGuide 5-FU | ✓ | ✓ |
| Thiopurine S-Methyltransferase (TPMT) Genotyping and Phenotyping for Predicting Response to Thiopurine Drug Therapy | ✓ | ✓ |
| UGT1A1 Sequence Variant Testing | ✓ | ✓ |
* Indicates insufficient evidence for full report.
